Trial Profile
Multicenter Prospective Trial to Investigate Accuracy of Ultrasound to Predict Relapse After Discontinuation of Infliximab and Efficacy/Safety of Readministration of Infliximab in Patients With Rheumatoid Arthritis in Low Disease Activity
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Diagnostic use
- Acronyms OPTIWIT
- 15 Jan 2021 Status changed from active, no longer recruiting to completed.
- 19 Aug 2020 Planned End Date changed from 31 Jul 2020 to 14 Aug 2020.
- 27 Sep 2019 Status changed from recruiting to active, no longer recruiting.